148
Participants
Start Date
June 30, 2014
Primary Completion Date
March 31, 2015
Study Completion Date
March 31, 2016
TEOSYAL® RHA Global Action
"A sterile, biodegradable, biocompatible, viscoelastic, clear, colorless, homogenized gel implant. It consists of cross-linked hyaluronic acid produced by fermentation of Streptococcus equi bacteria, formulated to a concentration of 23 mg/mL and 0.3% w/w lidocaine in a physiologic buffer. It is supplied in individual treatment syringes with 30G1/2 disposable sterile needles."
TEOSYAL® RHA Deep Lines
"A sterile, biodegradable, biocompatible, viscoelastic, clear, colorless, homogenized gel implant. It consists of cross-linked hyaluronic acid produced by fermentation of Streptococcus equi bacteria, formulated to a concentration of 23 mg/mL and 0.3% w/w lidocaine in a physiologic buffer. It is supplied in individual treatment syringes with 27G1/2 disposable sterile needles."
United States, Alabama, Birmingham
United States, California, Beverly Hills
United States, Santa Monica, Santa Monica
United States, Florida, Coral Gables
United States, Massachusetts, Chestnut Hill
ethica Clinical Research Inc.
INDUSTRY
Teoxane SA
INDUSTRY